ImmuneWatch DETECT
TCR specificity annotations for comprehensive T-cell response analysis.
Struggling with finding the epitope-specificity of your T-cell receptors?
ImmuneWatch’s DETECT platform uses machine learning to annotate the epitope specificity of T-cell receptor (TCR) sequences.
"Together with ImmuneWatch we were able to assess vaccine-induced T-cell signatures in our unique longitudinal sample collection of cancer patients. Based on antibody titers, it has previously been shown that cancer patients induce a weaker response towards COVID19 vaccines. T-cell immunity in this context is far less characterized and understood. Thanks to the ImmuneWatch DETECT platform we were able to take a deep dive into the SARS-CoV-2-specific T-cell response of our cancer patient cohort. "
ImmuneWatch DETECT wins Machine Learning competition
We are excited to share our recent win in the IMMREP23 Kaggle competition focused on TCR (T-cell receptor) specificity prediction.
Read the articleOur offering
Make your vaccine design process more data-driven by implementing machine learning and approaches from reverse vaccinology.
Reverse vaccinology as a service
TCR Sequencing Whitepaper
TCR sequencing for cancer vaccine development
To know the efficacy of your cancer vaccine, it is crucial to analyse the T cell response. Because of its versatility, TCR sequencing is a rising tool to monitor such immune responses. However, the full potential of TCR sequencing remains unrealised at present.
This white paper is directed toward researchers and developers of therapeutic cancer vaccines. It offers a brief overview of TCR sequencing and how it has been applied in the field of therapeutic cancer vaccination. Additionally, we highlight common challenges encountered in the data analysis and present examples of how these can be overcome with state-of-the-art data analysis techniques.
Our offering
For industry professionals we offer a tailored and feature-rich version of ImmuneWatch DETECT, designed to meet industry-specific needs. In addition, ImmuneWatch supports research and education. ImmuneWatch DETECT is therefore free to use for academics and non-profit organisations. This dual approach aims to advance both academic and professional pursuits in our field.